IRLAB Therapeutics: IRLAB Reports That Board Member Leaves the Company's Board
GOTHENBURG, SE / ACCESSWIRE / February 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 21, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering